FDA Approves FoundationOne® Liquid CDx as Companion Diagnostic for Itovebi™ (inavolisib) to Identify Hormone Receptor-Positive, HER2-Negative Breast Cancer Patients with PIK3CA Mutation
Roche’s VENTANA CLDN18 (43-14A) RxDx Assay for Identifying Gastric and GEJ Cancer Patients Receives CE Mark Approval
Tempest and Roche Partner to Advance Amezalpat Combination Therapy into First-Line Hepatocellular Carcinoma Pivotal Trial
Singapore to Expand MediShield Life Coverage for Precision Medicine and Strengthen Genetic Data Protections
Bayer and MOMA Therapeutics Partner to Advance Precision Oncology Therapies
DermTech's Non-Invasive Genomic Testing Shows Promise in Differentiating Melanoma from Atypical Moles
Velsera and Diagnostic Longwood Partner to Accelerate Precision Medicine in Spain and Portugal
Aurigene Oncology Reports Promising Phase 1 Results for India’s First CAR-T Cell Therapy in Multiple Myeloma
Agilus Diagnostics Launches Pharmacogenomics Testing Service to Revolutionize Personalized Medicine
Delhi High Court Orders Creation of National Rare Diseases Fund and Key Reforms for Patient Treatment
Myriad Genetics and Ultima Genomics Partner to Revolutionize Genetic Testing with UG 100 Sequencing Platform
FDA Approves Exact Sciences' Cologuard Plus™ for Enhanced Colorectal Cancer Screening
Datar Cancer Genetics Limited Welcomes Dr. Prashant Kumar as Chief Scientific Officer
WHO Approves First Emergency Use Mpox Diagnostic Test
A New Hope: Odisha's First Successful CAR-T Cell Therapy Saves Young Life